Dachaigh › Pheochromocytoma › Maryland
Sgrùdaidhean clionaigeach Pheochromocytoma ann an Maryland
Tha 10 sgrùdaidhean airson Pheochromocytoma a’ lorg phàirtichean aig làraichean ann an Maryland.
Bailtean ann an Maryland
Teacsa sgrùdaidh oifigeil (Beurla)
Diagnosis of Pheochromocytoma
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 1
Aoisean 3 gu 120 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT00004847[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06479811Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - Developmental Therapeutics ( Site 0108), Baltimore
- National Institutes of Health ( Site 0125), Bethesda
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04924075Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 2
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03206060Project: Every Child for Younger Patients With Cancer
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- agus 1 a bharrachd
A’ fastadhSgrùdadh amharc
Suas gu aois 25 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT02402244Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT00001238Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 1/2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06427798A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 15 Ògmh 2026 · NCT0604151618F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT06503146Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Johns Hopkins, Baltimore
A’ fastadhÌre 1/2
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT05636618Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.